(Q33900903)

29 July 2017

1 reference

title

Mechanism of action in thalidomide teratogenesis (English)

1 reference

29 July 2017

0 references

Stephens TD

1

1 reference

29 July 2017

Bunde CJ

series ordinal

2

1 reference

29 July 2017

Fillmore BJ

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

29 July 2017

Biochemical Pharmacology

1 reference

29 July 2017

59

1 reference

29 July 2017

1489-1499

1 reference

29 July 2017

12

1 reference

Hypothesis: thalidomide embryopathy-proposed mechanism of action

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

THALIDOMIDE AND CONGENITAL ABNORMALITIES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Die Thalidomid-Embryopathie*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

7 January 2021

The thalidomide syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

A short history of thalidomide embryopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Comments on "Proposed Mechanisms of Action in Thalidomide Embryopathy"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Immunosuppression by thalidomide: implications for teratology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide treatment for chronic graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide for the treatment of chronic graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide inhibits the replication of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide is an inhibitor of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide, a current teratogen in South America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Proposed mechanisms of action in thalidomide embryopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Oxidative damage in chemical teratogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Was tumour necrosis factor-alpha responsible for the fetal malformations associated with thalidomide in the early 1960s?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

A developmental model for thalidomide defects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

A series of normal stages in the development of the chick embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Limbness in the early chick embryo lateral plate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Embryotoxicity and teratogenicity of derivatives of 1,3-indandion (author's transl)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Teratogenicity and embryotoxicity of some maleinimides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Interaction of [glutarimide-2-14C]-thalidomide with rat embryonic DNA in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Structures of zinc finger domains from transcription factor Sp1. Insights into sequence-specific protein-DNA recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Comprehensive DNA recognition through concerted interactions from adjacent zinc fingers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Participation of oligomerization through C-terminal D domain region of Sp1 in DNA binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Differing roles for zinc fingers in DNA recognition: structure of a six-finger transcription factor IIIA complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Sp1 binds two sites in the CD11c promoter in vivo specifically in myeloid cells and cooperates with AP1 to activate transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Multiple specific contacts between a mammalian transcription factor and its cognate promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Transcription factor Sp1 recognizes promoter sequences from the monkey genome that are simian virus 40 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Bidirectional SV40 transcription mediated by tandem Sp1 binding interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Synergistic activation by the glutamine-rich domains of human transcription factor Sp1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

A functional Sp1 binding site is essential for the activity of the adult liver-specific human insulin-like growth factor II promoter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Insulin-like growth factor gene expression during rat embryonic development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Expression of insulin-like growth factor-I during chicken development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Genes for the insulin receptor and the insulin-like growth factor I receptor are expressed in the chicken embryo blastoderm and throughout organogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Functional characterization of insulin and IGF-I receptors in chicken lens epithelial and fiber cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Transient expression of insulin-like growth factor I immunoreactivity by vascular cells during angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Insulin-like growth factor I and II and insulin-like growth factor binding protein-2 RNAs are expressed in adjacent tissues within rat embryonic and fetal limbs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

A growth-promoting influence from the mesonephros during limb outgrowth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Effects of the mesonephros and insulin-like growth factor I on chondrogenesis of limb explants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Coordinate expression of IGF‐I and its receptor during limb outgrowth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Insulin-like growth factor I and its binding proteins in the cardiovascular system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Studies on insulin-like growth factor-I and insulin in chick limb morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

IGF-I and insulin in the acquisition of limb-forming ability by the embryonic lateral plate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Analysis of the human type I insulin-like growth factor receptor promoter region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

FGF-4 and BMP-2 have opposite effects on limb growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

FGF-4 replaces the apical ectodermal ridge and directs outgrowth and patterning of the limb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Basic FGF maintains some characteristics of the progress zone of chick limb bud in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Function of FGF-4 in limb development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Sonic hedgehog and Fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

FGF-2: apical ectodermal ridge growth signal for chick limb development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

A role for FGF-8 in the initiation and maintenance of vertebrate limb bud outgrowth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Hst-1 (FGF-4) antisense oligonucleotides block murine limb development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

FGF-2 influences cell movements and gene expression during limb development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

The ectodermal control in chick limb development: Wnt-7a, Shh, Bmp-2 and Bmp-4 expression and the effect of FGF-4 on gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

FGF can induce outgrowth of somatic mesoderm both inside and outside of limb-forming regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Fibroblast growth factors induce additional limb development from the flank of chick embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Limb development. The budding role of FGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Adhesion-growth factor interactions during differentiation: an integrated biological response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Ability of FGFs to promote the outgrowth and proliferation of limb mesoderm is dependent on IGF-I activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Hensen's node provides an endogenous limb-forming signal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Characterization of the entire transcription unit of the mouse fibroblast growth factor 1 (FGF-1) gene. Tissue-specific expression of the FGF-1.A mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

NF-Y binds to the CCAAT box motif of the FGF-4 gene and promotes FGF-4 expression in embryonal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Ontogeny of receptors for insulin-like peptides in chick embryo tissues: early dominance of insulin-like growth factor over insulin receptors in brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

IGF-I: a mitogen also involved in differentiation processes in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

The regulation of IGF-I receptor gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Cloning and Characterization of the Human Insulin-Like Growth Factor-I Receptor Gene 5′-Flanking Region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

The insulin-like growth factor family of ligands, receptors, and binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Functional characterization of the insulin-like growth factor I receptor on Jurkat T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Control of insulin-like growth factor (IGF) action by regulation of IGF-I receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Insulin-like growth factor induces phosphorylation of immunoreactive insulin receptor substrate and its association with phosphatidylinositol-3 kinase in human thymocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

The IRS-1 signaling system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Role of IRS-2 in insulin and cytokine signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Effect of tyrosine mutations on the kinase activity and transforming potential of an oncogenic human insulin-like growth factor I receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Genomic structure and complete sequence of the human FGFR4 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Expression of fibroblast growth factor receptor-1 in rat heart H9c2 myoblasts increases cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Regulation of the fibroblast growth factor receptor 3 promoter and intron I enhancer by Sp1 family transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Differential regulation of urokinase-type plasminogen activator expression by basic fibroblast growth factor and serum in myogenesis. Requirement of a common mitogen-activated protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Characterization of the promoter region of the murine fibroblast growth factor receptor 1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Mapping of a transcription element critical for expression of the fibroblast growth factor receptor 1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Requirement of vascular integrin alpha v beta 3 for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

The integrin alpha v gene: identification and characterization of the promoter region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Characterization of the integrin alpha(v) gene promoter in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide derivatives and the immune system. 6. Effects of two derivatives with no obvious teratogenic potency on the pattern of integrins and other surface receptors on blood cells of marmosets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Myoblast alpha v beta3 integrin levels are controlled by transcriptional regulation of expression of the beta3 subunit and down-regulation of beta3 subunit expression is required for skeletal muscle cell differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Regulation of vascular endothelial growth factor expression by insulin-like growth factor I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains: potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Confocal microscopic analysis of integrin expression on the microvasculature and its sprouts in the neonatal foreskin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Thalidomide inhibits corneal angiogenesis induced by vascular endothelial growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Genomic organization of human and mouse genes for vascular endothelial growth factor C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Integrins, angiogenesis and vascular cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Teratological tests of the hydrolysis products of thalidomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

The teratogenic activity of a thalidomide analogue, EM 12 in rabbits, rats, and monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

Amino-substituted thalidomide analogs: potent inhibitors of TNF-alpha production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

The regulation of IGF-I receptor gene expression by positive and negative zinc-finger transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900388-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(99)00388-3

1 reference

29 July 2017

1 reference